company background image
CLS1 logo

McKesson Europe HMSE:CLS1 Stock Report

Last Price

€24.40

Market Cap

€5.0b

7D

0%

1Y

9.9%

Updated

27 Jun, 2023

Data

Company Financials

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

CLS1 Stock Overview

McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide.

CLS1 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends1/6

McKesson Europe AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for McKesson Europe
Historical stock prices
Current Share Price€24.40
52 Week High€24.50
52 Week Low€19.80
Beta0.13
1 Month Change0.83%
3 Month Change0.83%
1 Year Change9.91%
3 Year Change-6.51%
5 Year Change-7.58%
Change since IPO-6.51%

Recent News & Updates

Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)

Dec 23
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)

These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong

Sep 01
These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong

Recent updates

Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)

Dec 23
Estimating The Fair Value Of McKesson Europe AG (HMSE:CLS1)

These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong

Sep 01
These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong

These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong

May 19
These Return Metrics Don't Make McKesson Europe (HMSE:CLS1) Look Too Strong

McKesson Europe (HMSE:CLS1) Could Be Struggling To Allocate Capital

Jan 27
McKesson Europe (HMSE:CLS1) Could Be Struggling To Allocate Capital

Capital Allocation Trends At McKesson Europe (HMSE:CLS1) Aren't Ideal

Sep 07
Capital Allocation Trends At McKesson Europe (HMSE:CLS1) Aren't Ideal

McKesson Europe (HMSE:CLS1) Will Be Looking To Turn Around Its Returns

Apr 29
McKesson Europe (HMSE:CLS1) Will Be Looking To Turn Around Its Returns

What You Need To Know About McKesson Europe AG's (HMSE:CLS1) Investor Composition

Mar 20
What You Need To Know About McKesson Europe AG's (HMSE:CLS1) Investor Composition

Is McKesson Europe AG (HMSE:CLS1) A Risky Dividend Stock?

Feb 13
Is McKesson Europe AG (HMSE:CLS1) A Risky Dividend Stock?

Shareholder Returns

CLS1DE HealthcareDE Market
7D0%-3.2%1.9%
1Y9.9%-1.8%7.3%

Return vs Industry: CLS1 exceeded the German Healthcare industry which returned -12.8% over the past year.

Return vs Market: CLS1 exceeded the German Market which returned 1.4% over the past year.

Price Volatility

Is CLS1's price volatile compared to industry and market?
CLS1 volatility
CLS1 Average Weekly Movement0.7%
Healthcare Industry Average Movement5.3%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: CLS1 has not had significant price volatility in the past 3 months.

Volatility Over Time: CLS1's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18356,808Sebastian Ringhttps://www.mckesson.eu/mck-en

McKesson Europe AG provides logistics and other services to the pharmaceutical and healthcare sectors worldwide. The company operates through two divisions, Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution division engages in the wholesale of pharmaceutical and other health care products.

McKesson Europe AG Fundamentals Summary

How do McKesson Europe's earnings and revenue compare to its market cap?
CLS1 fundamental statistics
Market cap€4.96b
Earnings (TTM)-€54.30m
Revenue (TTM)€9.26b

0.5x

P/S Ratio

-91.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CLS1 income statement (TTM)
Revenue€9.26b
Cost of Revenue€8.46b
Gross Profit€792.30m
Other Expenses€846.60m
Earnings-€54.30m

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.27
Gross Margin8.56%
Net Profit Margin-0.59%
Debt/Equity Ratio0.3%

How did CLS1 perform over the long term?

See historical performance and comparison

Dividends

3.4%

Current Dividend Yield

n/a

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.